Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Johnson & Johnson

Symbol: JNJ     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
2.86%
Current Price
$132.81
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 10:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
20,021,000,000
20,021,000,000
6,615,000,000
13,406,000,000
8,967,000,000
4,439,000,000
3,749,000,000
41,987,000,000
150,027,000,000
91,072,000,000
58,955,000,000
14,734,000,000
1,708,000,000
15,336,000,000
29,368,000,000
-3,390,000,000
3,543,000,000
 
3,748,000,000

Financials 2018

Update: 2019-06-09 10:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
20,394,000,000
20,394,000,000
6,961,000,000
13,433,000,000
9,215,000,000
4,218,000,000
3,042,000,000
46,033,000,000
152,954,000,000
93,202,000,000
59,752,000,000
18,107,000,000
2,796,000,000
19,687,000,000
30,480,000,000
2,083,000,000
6,244,000,000
 
3,224,000,000

Q 3

2018-09-30
20,348,000,000
20,348,000,000
6,589,000,000
13,759,000,000
9,177,000,000
4,582,000,000
3,934,000,000
47,194,000,000
155,703,000,000
91,077,000,000
64,626,000,000
16,056,000,000
1,773,000,000
19,364,000,000
31,253,000,000
-1,474,000,000
6,272,000,000
 
3,634,000,000

Q 2

2018-06-30
20,830,000,000
20,830,000,000
6,927,000,000
13,903,000,000
8,382,000,000
5,521,000,000
3,954,000,000
45,438,000,000
155,365,000,000
92,476,000,000
62,889,000,000
17,569,000,000
2,678,000,000
18,139,000,000
32,083,000,000
3,204,000,000
6,079,000,000
 
2,639,000,000

Q 1

2018-03-31
20,009,000,000
20,009,000,000
6,614,000,000
13,395,000,000
7,667,000,000
5,728,000,000
4,367,000,000
42,768,000,000
156,625,000,000
93,370,000,000
63,255,000,000
14,639,000,000
2,696,000,000
15,204,000,000
32,533,000,000
-3,289,000,000
3,606,000,000
 
2,404,000,000

Financials 2017

Update: 2019-06-09 10:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
20,195,000,000
20,195,000,000
7,174,000,000
13,021,000,000
9,956,000,000
3,065,000,000
-10,713,000,000
43,088,000,000
157,303,000,000
97,143,000,000
60,160,000,000
17,824,000,000
3,906,000,000
18,296,000,000
34,581,000,000
2,063,000,000
6,105,000,000
 
4,011,000,000